The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Type 1 Diabetes—A Clinical Perspective
Open accessAbstract
Type 1 diabetes mellitus is a disorder of glucose regulation characterized by autoimmune destruction of the insulin-producing pancreatic β-cells and the need for lifelong insulin replacement therapy. Both glucose and HbA1c criteria are available for the diagnosis of diabetes. Achieving and maintaining near-normal blood glucose concentrations with appropriate administration of insulin is critical for successful long-term care of patients with diabetes mellitus and prevention of diabetic complications, but it is very difficult to achieve. Efforts to intensify therapy usually result in hypoglycemia. Point-of-care blood glucose testing provides the information needed by patients for clinical decision-making. Despite the ease of use and rapid reporting of modern point-of-care glucose monitoring devices, they provide measurements only intermittently. Continuous glucose monitoring devices can provide new glucose measurements every 5 minutes and may facilitate better glucose control. The development of new technologies that integrate continuous glucose monitoring technology with insulin pumps and a control algorithm to create a system for automated insulin delivery has the potential to significantly improve glycemic control, reduce hypoglycemia, and reduce the burden of care in type 1 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Eisenbarth (1986) · doi:10.1056/nejm198605223142106 · Cited by 1,659
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Hypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes
Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559
Research works printed but not linked: 20
- 2016, Classification and diagnosis of diabetes. Standard of Medical Care in Diabetes, Diabetes Care, 39, S13, 10.2337/dc16-S005 · DOI · Paper page
- 2012, Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay, Diabetes Care, 35, 465, 10.2337/dc11-1236 · DOI · Paper page
- 2015, Low levels of C-peptide have clinical significance for established Type 1 diabetes, Diabet Med, 32, 1346, 10.1111/dme.12850 · DOI · Paper page
- 2015, Current concepts on the pathogenesis of type 1 diabetes—considerations for attempts to prevent and reverse the disease, Diabetes Care, 38, 979, 10.2337/dc15-0144 · DOI
- 1999, Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation, J Immunol, 163, 525, 10.4049/jimmunol.163.1.525 · DOI
- 2013, Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry, J Clin Endocrinol Metab, 98, 3411, 10.1210/jc.2013-1589 · DOI · Paper page
- 2010, 2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement, Diabetes Care, 33, 1903, 10.2337/dc10-0953 · DOI · Paper page
- 2016, Glycemic Targets. Standards of Medical Care in Diabetes—2016, Diabetes Care, 39, S39
- 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
- 2011, Point-of-care blood test for ketones in patients with diabetes: primary care diagnostic technology update, Br J Gen Pract, 61, 530, 10.3399/bjgp11X588600 · DOI
- 2007, Improving outcomes with POCT for HbA1c and blood ketone testing, J Diabetes Sci Technol, 1, 133, 10.1177/193229680700100122 · DOI
- 2002, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus, JAMA, 287, 2563, 10.1001/jama.287.19.2563 · DOI · Paper page
- 2014, Closed-loop artificial pancreas systems: engineering the algorithms, Diabetes Care, 37, 1191, 10.2337/dc13-2108 · DOI · Paper page
- 2014, The artificial pancreas: current status and future prospects in the management of diabetes, Ann N Y Acad Sci, 1311, 102, 10.1111/nyas.12431 · DOI · Paper page
- 2014, Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study, Diabetes Care, 37, 1931, 10.2337/dc13-2911 · DOI
- 2014, Outpatient glycemic control with a bionic pancreas in type 1 diabetes, N Engl J Med, 371, 313, 10.1056/NEJMoa1314474 · DOI · Paper page
- 2006, Feasibility of automating insulin delivery for the treatment of type 1 diabetes, Diabetes, 55, 3344, 10.2337/db06-0419 · DOI · Paper page
- 2010, Efficacy determinants of subcutaneous microdose glucagon during closed-loop control, J Diabetes Sci Technol, 4, 1288, 10.1177/193229681000400602 · DOI
- 2014, Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes, J Clin Endocrinol Metab, 99, 1701, 10.1210/jc.2013-4151 · DOI
- 2016, Development of a microsphere-based system to facilitate real-time insulin monitoring, J Diabetes Sci Technol, 10, 689, 10.1177/1932296815625081 · DOI
Cited by
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
Benton, M., Cleal, B., Prina, M., Baykoca, J., Willaing, I., Price, H., & Ismail, K. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.11.004 · Cited by 58
Gene therapy - can it cure type 1 diabetes
Srinivasan, M., Thangaraj, S. R., & Arzoun, H. (2021) · Cureus · doi:10.7759/cureus.20516 · Cited by 11
Maqusood, S., Chakole, V., & Dash, S. (2024) · Cureus · doi:10.7759/cureus.60426 · Cited by 3
Metadata
- Authors
- Kahanovitz, L., Sluss, P. M., & Russell, S. J.
- Venue
- Point of Care: The Journal of Near-Patient Testing & Technology
- Published
- 2017-03
- Volume
- 16
- Issue
- 1
- Pages
- 37-40
- ISSN
- 1533-029X (ISSN-L)
- 1533-0303
- OpenAlex
- W2589143196
- Cited by
- 169
- References
- 15
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type 1 Diabetes—A Clinical Perspective. https://app.cochat.ai/papers/10.1097/poc.0000000000000125
- The paper
- Kahanovitz, L., Sluss, P. M., & Russell, S. J. (2017). Type 1 Diabetes—A Clinical Perspective. Point of Care: The Journal of Near-Patient Testing & Technology. https://doi.org/10.1097/poc.0000000000000125
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.